Logo image of ATEX

ANTERIX INC (ATEX) Stock Fundamental Analysis

NASDAQ:ATEX - US03676C1009 - Common Stock

22.27 USD
-0.2 (-0.89%)
Last: 9/4/2025, 4:36:48 PM
22.27 USD
0 (0%)
After Hours: 9/4/2025, 4:36:48 PM
Fundamental Rating

4

ATEX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 36 industry peers in the Diversified Telecommunication Services industry. The financial health of ATEX is average, but there are quite some concerns on its profitability. ATEX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ATEX was profitable.
In the past year ATEX has reported a negative cash flow from operations.
ATEX had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ATEX reported negative operating cash flow in multiple years.
ATEX Yearly Net Income VS EBIT VS OCF VS FCFATEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

ATEX has a better Return On Assets (8.16%) than 94.44% of its industry peers.
ATEX has a Return On Equity of 15.87%. This is amongst the best in the industry. ATEX outperforms 86.11% of its industry peers.
Industry RankSector Rank
ROA 8.16%
ROE 15.87%
ROIC N/A
ROA(3y)-4.03%
ROA(5y)-9.42%
ROE(3y)-7.34%
ROE(5y)-13.55%
ROIC(3y)N/A
ROIC(5y)N/A
ATEX Yearly ROA, ROE, ROICATEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20 -25

1.3 Margins

The Profit Margin of ATEX (495.14%) is better than 100.00% of its industry peers.
ATEX does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 495.14%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATEX Yearly Profit, Operating, Gross MarginsATEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K

More info and screens

5

2. Health

2.1 Basic Checks

ATEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATEX has been increased compared to 1 year ago.
The number of shares outstanding for ATEX has been increased compared to 5 years ago.
There is no outstanding debt for ATEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ATEX Yearly Shares OutstandingATEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
ATEX Yearly Total Debt VS Total AssetsATEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -0.32, we must say that ATEX is in the distress zone and has some risk of bankruptcy.
ATEX has a Altman-Z score of -0.32. This is amonst the worse of the industry: ATEX underperforms 83.33% of its industry peers.
There is no outstanding debt for ATEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.32
ROIC/WACCN/A
WACC8.86%
ATEX Yearly LT Debt VS Equity VS FCFATEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

ATEX has a Current Ratio of 1.54. This is a normal value and indicates that ATEX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.54, ATEX is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
ATEX has a Quick Ratio of 1.54. This is a normal value and indicates that ATEX is financially healthy and should not expect problems in meeting its short term obligations.
ATEX's Quick ratio of 1.54 is fine compared to the rest of the industry. ATEX outperforms 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.54
ATEX Yearly Current Assets VS Current LiabilitesATEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 197.50% over the past year.
ATEX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.02%.
Measured over the past years, ATEX shows a very strong growth in Revenue. The Revenue has been growing by 31.05% on average per year.
EPS 1Y (TTM)197.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%260.71%
Revenue 1Y (TTM)16.02%
Revenue growth 3Y77.41%
Revenue growth 5Y31.05%
Sales Q2Q%-7.02%

3.2 Future

ATEX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -47.84% yearly.
The Revenue is expected to grow by 0.27% on average over the next years.
EPS Next Y330.71%
EPS Next 2Y-47.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.8%
Revenue Next 2Y0.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ATEX Yearly Revenue VS EstimatesATEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M
ATEX Yearly EPS VS EstimatesATEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ATEX is valuated correctly with a Price/Earnings ratio of 14.28.
ATEX's Price/Earnings ratio is rather cheap when compared to the industry. ATEX is cheaper than 83.33% of the companies in the same industry.
When comparing the Price/Earnings ratio of ATEX to the average of the S&P500 Index (27.03), we can say ATEX is valued slightly cheaper.
ATEX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 14.28
Fwd PE N/A
ATEX Price Earnings VS Forward Price EarningsATEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATEX Per share dataATEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A cheap valuation may be justified as ATEX's earnings are expected to decrease with -47.84% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y-47.84%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ATEX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANTERIX INC

NASDAQ:ATEX (9/4/2025, 4:36:48 PM)

After market: 22.27 0 (0%)

22.27

-0.2 (-0.89%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-11 2025-11-11
Inst Owners89.12%
Inst Owner Change2.75%
Ins Owners1.67%
Ins Owner Change1.93%
Market Cap417.34M
Analysts82.22
Price Target59.16 (165.65%)
Short Float %5.87%
Short Ratio4.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)268.32%
Min EPS beat(2)204.43%
Max EPS beat(2)332.2%
EPS beat(4)3
Avg EPS beat(4)173.28%
Min EPS beat(4)-14.66%
Max EPS beat(4)332.2%
EPS beat(8)5
Avg EPS beat(8)93.76%
EPS beat(12)9
Avg EPS beat(12)92.77%
EPS beat(16)10
Avg EPS beat(16)46.16%
Revenue beat(2)0
Avg Revenue beat(2)-14.1%
Min Revenue beat(2)-20.4%
Max Revenue beat(2)-7.8%
Revenue beat(4)0
Avg Revenue beat(4)-13.97%
Min Revenue beat(4)-20.4%
Max Revenue beat(4)-7.8%
Revenue beat(8)1
Avg Revenue beat(8)-9.56%
Revenue beat(12)1
Avg Revenue beat(12)-22.41%
Revenue beat(16)2
Avg Revenue beat(16)-18.14%
PT rev (1m)-19.44%
PT rev (3m)-33.71%
EPS NQ rev (1m)-7.14%
EPS NQ rev (3m)-15.38%
EPS NY rev (1m)501.41%
EPS NY rev (3m)281.92%
Revenue NQ rev (1m)-7.37%
Revenue NQ rev (3m)-6.2%
Revenue NY rev (1m)-8.01%
Revenue NY rev (3m)-9.38%
Valuation
Industry RankSector Rank
PE 14.28
Fwd PE N/A
P/S 70.45
P/FCF N/A
P/OCF N/A
P/B 2.26
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.56
EY7%
EPS(NY)-1.38
Fwd EYN/A
FCF(TTM)-2.5
FCFYN/A
OCF(TTM)-1.6
OCFYN/A
SpS0.32
BVpS9.86
TBVpS-4.3
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.16%
ROE 15.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 495.14%
GM N/A
FCFM N/A
ROA(3y)-4.03%
ROA(5y)-9.42%
ROE(3y)-7.34%
ROE(5y)-13.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3397.16%
Cap/Sales 282.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.54
Altman-Z -0.32
F-Score6
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)2427.57%
Cap/Depr(5y)1914.89%
Cap/Sales(3y)709.4%
Cap/Sales(5y)1241.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)197.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%260.71%
EPS Next Y330.71%
EPS Next 2Y-47.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.02%
Revenue growth 3Y77.41%
Revenue growth 5Y31.05%
Sales Q2Q%-7.02%
Revenue Next Year-6.8%
Revenue Next 2Y0.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.21%
OCF growth 3YN/A
OCF growth 5YN/A